Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1990-05-11
1994-11-29
Walsh, Stephen G.
Drug, bio-affecting and body treating compositions
Lymphokine
514 4, 514 8, 514 21, 530351, A61K 3766, A61K 3702, C07K 1526
Patent
active
053688538
ABSTRACT:
The present invention relates to a method of treating a viral infection in an animal. The method comprises administering to said animal leukoregulin alone or in combination with an anti-viral chemotherapeutic agent. The invention further relates to a pharmaceutical composition suitable for use in such a method.
REFERENCES:
patent: 4495190 (1985-01-01), Hagberg et al.
patent: 4849506 (1989-07-01), Ransom et al.
patent: 5082657 (1992-01-01), Ranson
Natsumeda et al., Biochemical and Biophysical Research Communications 153:321-327, May 1988.
Papermaster et al., in Lymphokines and Thymic Hormones, Raven Press, N.Y., 1981, pp. 289-299.
G. B. Elion et al., Proc. Natl. Acad. Sci. 74:5716-5720, 1977.
Ransom et al, Introduction, pp. 3-8 (1988), in Leukolysins & Cancer.
Ransom et al, Leukoregulin, Biology, Biochemistry, and Mode of Action, pp. 169-187 (1988), in Leukolysins & Cancer.
Ransom et al, Leukoregulin, Potential as a Clinical Cancer Therapeutic Agent, pp. 313-317 (1988), in Leukolysins & Cancer.
Barnett et al, Leukoregulin-increased Plasma Membrane Permeability and Associated Ionic Fluxes, Cancer Research vol. 46, 2686-2692, Jun. 1986.
Ransom et al, Leukoregulin, a Direct-acting Anticancer Immunological Hormone That Is Distinct from Lymphotoxin and Interferon, Cancer Research 45:851-862, Feb. 1985.
Detrick Barbara
Evans Charles H.
Hooks John J.
Office of Technology Transfer National Institutes of Health
The United States of America as represented by the Secretary of
Walsh Stephen G.
LandOfFree
Leukoregulin anti-viral therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Leukoregulin anti-viral therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leukoregulin anti-viral therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-72510